Sten Madsbad
#111,615
Most Influential Person Now
Researcher
Sten Madsbad's AcademicInfluence.com Rankings
Sten Madsbadcomputer-science Degrees
Computer Science
#4230
World Rank
#4451
Historical Rank
Data Science
#47
World Rank
#48
Historical Rank
Computational Linguistics
#364
World Rank
#370
Historical Rank
Machine Learning
#768
World Rank
#779
Historical Rank
Sten Madsbadmathematics Degrees
Mathematics
#5484
World Rank
#7711
Historical Rank
Measure Theory
#754
World Rank
#1012
Historical Rank
Download Badge
Computer Science Mathematics
Sten Madsbad's Degrees
- PhD Computer Science University of Copenhagen
- Masters Mathematics Aarhus University
- Bachelors Physics Technical University of Denmark
Similar Degrees You Can Earn
Why Is Sten Madsbad Influential?
(Suggest an Edit or Addition)Sten Madsbad's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study (2002) (1320)
- Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. (2004) (907)
- Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. (2001) (893)
- Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. (2001) (865)
- The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. (2003) (556)
- Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. (2003) (505)
- Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients (2002) (492)
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (2017) (406)
- Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects (2003) (391)
- Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. (1999) (357)
- Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial. (2004) (331)
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes (2009) (327)
- Reduced Incretin Effect in Type 2 Diabetes (2007) (311)
- Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects (2012) (304)
- Low birthweight is associated with specific changes in muscle insulin-signalling protein expression (2005) (300)
- Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. (2012) (274)
- Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. (2007) (261)
- Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes (2013) (249)
- Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. (2014) (246)
- Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes (2011) (232)
- Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota (2016) (228)
- Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass (2014) (219)
- The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. (2003) (215)
- Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus (2008) (213)
- Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass (2013) (211)
- Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. (1979) (211)
- Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists (2015) (210)
- Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. (1995) (201)
- Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. (2009) (198)
- Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis (1982) (196)
- Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. (2002) (190)
- An overview of once‐weekly glucagon‐like peptide‐1 receptor agonists—available efficacy and safety data and perspectives for the future (2011) (188)
- Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes (2008) (186)
- Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. (2003) (183)
- Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. (2006) (179)
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial (2008) (176)
- Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. (2001) (173)
- Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass (2012) (172)
- Decreased insulin removal contributes to hyperinsulinemia in obesity. (1981) (171)
- Hypomagnesemia, a Risk Factor in Diabetic Retinopathy (1978) (169)
- Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus (2007) (164)
- Glucagon-like peptide-1, glucose homeostasis and diabetes. (2008) (164)
- Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. (1983) (162)
- Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function (2011) (161)
- Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux‐en‐Y gastric bypass (2013) (159)
- Proteomics reveals the effects of sustained weight loss on the human plasma proteome (2016) (157)
- Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. (2001) (155)
- Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? (2014) (153)
- Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity (2012) (150)
- The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes (2007) (146)
- Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function (2011) (144)
- The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men (2009) (138)
- Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes. (2002) (138)
- Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight. (2007) (138)
- G-allele of Intronic rs10830963 in MTNR1B Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release (2009) (136)
- Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results. (2009) (132)
- Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. (1979) (131)
- Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery (2016) (128)
- Incretin-Based Therapies (2009) (127)
- Ghrelin receptor agonist (TZP‐101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis (2009) (122)
- Hormonal, Metabolic, and Cardiovascular Responses to Hypoglycemia in Diabetic Autonomic Neuropathy (1981) (121)
- Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss☆ (2018) (121)
- Reduced Incretin Effect in Type 2 Diabetes - Cause or Consequence of the Diabetic State? Received for publication 23 January 2007 and accepted in revised form 3 May 2007. (2007) (119)
- Prevalence of Residual Beta-cell Function in Insulin-Dependent Diabetics in Relation to Age at Onset and Duration of Diabetes (1978) (119)
- Studies of the Pro12Ala polymorphism of the ppar-γ gene in the Danish MONICA cohort: Homozygosity of the Ala allele confers a decreased risk of the Insulin Resistance syndrome (2002) (118)
- Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia (1998) (117)
- The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications (2014) (117)
- Twelve weeks treatment with the DPP‐4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non‐glucose induced insulin secretion in patients with type 2 diabetes mellitus (2010) (115)
- Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans (2010) (114)
- The effect of intense exercise on postprandial glucose homeostasis in Type II diabetic patients (1999) (113)
- Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin (2000) (113)
- Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus. (1987) (111)
- The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. (2000) (108)
- Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion (2009) (107)
- The Effect of Glucagon-Like Peptide I (GLP-I) on Glucose Elimination in Healthy Subjects Depends on the Pancreatic Glucoregulatory Hormones (1996) (106)
- GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women. (2015) (106)
- Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials (2008) (102)
- Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial. (2016) (100)
- Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. (2007) (99)
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. (2021) (96)
- Hypoparathyroidism in diabetes mellitus. (1981) (96)
- Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals (2013) (96)
- CRP and suPAR are differently related to anthropometry and subclinical organ damage. (2013) (91)
- Altered fat tissue distribution in young adult men who had low birth weight. (2005) (90)
- Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. (2015) (88)
- Pleiotropic Effects of GIP on Islet Function Involve Osteopontin (2011) (88)
- Development of bone mineral loss in insulin‐treated diabetes: a 1 1/2 years follow‐up study in sixty patients (1981) (88)
- Altered PI3-Kinase/Akt Signalling in Skeletal Muscle of Young Men with Low Birth Weight (2008) (85)
- Hyperzincuria in insulin treated diabetes mellitus--its relation to glucose homeostasis and insulin administration. (1981) (85)
- Changes in Platelet Function, Blood Coagulation and Fibrinolysis During Insulin-Induced Hypoglycaemia in Juvenile Diabetics and Normal Subjects (1982) (82)
- Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. (2008) (82)
- Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes (2008) (81)
- Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance (2013) (80)
- GLP‐1: physiological effects and potential therapeutic applications (2008) (80)
- Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. (1980) (78)
- Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes (2004) (78)
- Validation of methods for measurement of insulin secretion in humans in vivo. (2000) (78)
- Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus. (2009) (77)
- Insulin Signal Transduction in Skeletal Muscle From Glucose-Intolerant Relatives With Type 2 Diabetes (2001) (77)
- Influence of Smoking on Insulin Requirement and Metbolic Status in Diabetes Mellitus (1980) (77)
- Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes (2011) (76)
- Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass (2013) (75)
- Dietary intervention increases n‐3 long‐chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity (2006) (75)
- Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist. (2018) (74)
- Kinetics of Human C-peptide in Man (1978) (72)
- Liraglutide Effect and Action in Diabetes (LEAD™) trial (2009) (72)
- Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study (2015) (71)
- Postoperative Morbidity and Mortality in Type-2 Diabetics After Fast-Track Primary Total Hip and Knee Arthroplasty (2015) (71)
- Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus. (2016) (71)
- Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. (2019) (70)
- Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous Glucose (1983) (70)
- Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity. (2010) (69)
- No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP‐1 and intravenous glucose (2001) (69)
- Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1‐year multicentre study (2001) (69)
- Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss (2014) (69)
- Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36. (2016) (68)
- Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes. (2001) (68)
- Increased hepatic insulin clearance after Roux-en-Y gastric bypass. (2013) (66)
- A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial (2019) (66)
- Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. (1987) (65)
- Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration (2012) (65)
- The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects (2006) (65)
- Obesity – an indication for GLP‐1 treatment? Obesity pathophysiology and GLP‐1 treatment potential (2011) (64)
- On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans. (2010) (64)
- Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial (2016) (64)
- Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D. (1982) (64)
- Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability (2018) (64)
- Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men. (2015) (64)
- Adipose expression of adipocytokines in women with polycystic ovary syndrome. (2012) (63)
- Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. (2009) (63)
- Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients (1988) (62)
- Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery. (2018) (62)
- Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stress. (1983) (62)
- Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. (1999) (61)
- Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study (2016) (61)
- Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes (2012) (61)
- C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study (2008) (61)
- Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss. (2009) (61)
- Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass. (2015) (61)
- Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction (2009) (60)
- Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods (2001) (60)
- Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics. (1979) (59)
- Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving? (2016) (59)
- Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial (2019) (58)
- Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open‐label crossover trial (2017) (58)
- Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time (2009) (57)
- Large‐scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits (2005) (57)
- Beta-cell function and metabolic control in insulin treated diabetics. (1980) (57)
- Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. (2002) (56)
- Smoking reduces insulin absorption from subcutaneous tissue. (1982) (56)
- Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes. (2003) (56)
- Bariatric surgery - effects on obesity and related co-morbidities. (2014) (56)
- Intranasal insulin therapy: the clinical realities (1995) (55)
- β‐Cell function and glucose and lipid oxidation in Graves’ disease (1996) (55)
- Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. (2004) (54)
- Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. (2016) (54)
- Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation (2008) (52)
- Four weeks of near‐normalization of blood glucose has no effect on postprandial GLP‐1 and GIP secretion, but augments pancreatic B‐cell responsiveness to a meal in patients with Type 2 diabetes (2008) (52)
- Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass. (2015) (52)
- The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance (2007) (52)
- Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes (1983) (51)
- No response of pancreatic hormones to hypoglycemia in diabetic autonomic neuropathy. (1982) (51)
- Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. (1982) (51)
- Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists. (2009) (50)
- Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor. (2016) (50)
- Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells. (2002) (50)
- Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function. (2003) (50)
- Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment. (1980) (50)
- Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans (2011) (49)
- Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study (2016) (49)
- Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. (2009) (48)
- IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients. (2006) (48)
- Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery. (2015) (47)
- GLP-1 as a Mediator in the Remission of Type 2 Diabetes After Gastric Bypass and Sleeve Gastrectomy Surgery (2014) (46)
- Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. (2010) (46)
- Minor long‐term changes in weight have beneficial effects on insulin sensitivity and β‐cell function in obese subjects (2002) (45)
- Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. (2006) (45)
- KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. (2009) (44)
- The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women (2012) (44)
- No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis. (2003) (44)
- A low‐fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes (2006) (43)
- Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. (2000) (43)
- Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension (2011) (42)
- Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes (2015) (42)
- Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study (2016) (42)
- In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans. (2016) (42)
- Overnight glucose control in people with type 1 diabetes (2018) (41)
- The insulin-resistant phenotype of polycystic ovary syndrome. (2010) (41)
- The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes (2006) (40)
- Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV‐infected patients on highly active antiretroviral therapy (2005) (40)
- Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected]. (2001) (40)
- Comparable COVID‐19 outcomes with current use of GLP‐1 receptor agonists, DPP‐4 inhibitors or SGLT‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV‐2 (2021) (40)
- Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB (2015) (39)
- PASSIVE TRANSFER OF DIABETES MELLITUS FROM MAN TO MOUSE (1978) (39)
- Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome. (2018) (39)
- Model-Based Closed-Loop Glucose Control in Type 1 Diabetes: The DiaCon Experience (2013) (38)
- Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial. (2019) (38)
- Restoration of the insulinotropic effect of glucose‐dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase‐4 inhibitors (2015) (38)
- Changes in plasma volume, in transcapillary escape rate of albumin and in subcutaneous blood flow during hypoglycaemia in man. (1985) (37)
- Pancreatic beta cell secretion during oral and intravenous glucose administration. (2009) (37)
- Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) gene in Danish subjects with the metabolic syndrome (2005) (37)
- Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. (2005) (37)
- Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans? (2010) (37)
- Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men. (2003) (37)
- Mechanisms involved in follistatin‐induced hypertrophy and increased insulin action in skeletal muscle (2019) (37)
- Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals (2011) (36)
- Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial (2016) (36)
- Osteopenia in insulin treated diabetes mellitus (1978) (35)
- Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis. (1980) (35)
- Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes (2010) (35)
- GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men. (2019) (34)
- Effect of large weight reductions on measured and estimated kidney function (2017) (34)
- Measures of overweight and obesity and risk of cardiovascular disease: a population-based study (2010) (34)
- Effects of subcutaneous, low‐dose glucagon on insulin‐induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes (2016) (34)
- The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. (1999) (33)
- Prenatal exposure to persistent organochlorine pollutants is associated with high insulin levels in 5-year-old girls. (2015) (33)
- Bone loss in diabetes: Effects of metabolic state (1979) (33)
- Metformin monotherapy for adults with type 2 diabetes mellitus. (2018) (33)
- On the effects of human galanin in man (1993) (32)
- Overnight Control of Blood Glucose in People with Type 1 Diabetes (2012) (32)
- Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes. (2004) (32)
- Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome (2009) (32)
- Treatment of type 2 diabetes with incretin-based therapies (2009) (32)
- Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. (2005) (32)
- Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. (2005) (32)
- Study rationale and design of the CIMT trial: The Copenhagen Insulin and Metformin Therapy Trial (2009) (31)
- Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus. (1983) (31)
- Impaired Insulin-Stimulated Nonoxidative Glucose Metabolism in Pancreas-Kidney Transplant Recipients: Dose-Response Effects of Insulin on Glucose Turnover (1996) (31)
- Patient‐reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once‐daily human GLP‐1 analogue, liraglutide (2008) (31)
- Chenodeoxycholic acid stimulates glucagon‐like peptide‐1 secretion in patients after Roux‐en‐Y gastric bypass (2017) (31)
- Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics (1981) (30)
- Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis (2010) (29)
- The Effect of Residual Beta‐cell Function on the Development of Diabetic Retinopathy (1986) (29)
- Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy. (2016) (29)
- Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review (2016) (29)
- Skeletal muscle mitochondrial function in polycystic ovarian syndrome. (2011) (29)
- Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy. (2005) (29)
- Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus. (2019) (28)
- Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance (2015) (28)
- Body composition in adults with Type 1 diabetes at onset and during the first year of insulin therapy (2002) (28)
- Effect of sham-feeding on glucose tolerance and insulin secretion. (1987) (28)
- A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients (2018) (28)
- The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes (2007) (28)
- Semaglutide seems to be more effective the other GLP-1Ras. (2017) (27)
- Desaturation of Skeletal Muscle Structural and Depot Lipids in Obese Individuals during a Very‐Low‐Calorie Diet Intervention (2007) (27)
- Patients with Insulin-dependent Diabetes but not those with Non-insulin-dependent Diabetes have Anti-sulfatide Antibodies as Determined with a New ELISA Assay (2002) (26)
- Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation. (1996) (26)
- Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo‐controlled, double‐blind, parallel‐group study (2017) (26)
- The impact of gastric bypass surgery on sex hormones and menstrual cycles in premenopausal women (2017) (25)
- Changes in Hematology and Calcium Metabolism After Gastric Bypass Surgery—a 2-Year Follow-Up Study (2015) (25)
- Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes. (2002) (25)
- Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men (2017) (25)
- Outcome of the glucagon test depends upon the prevailing blood glucose concentration in type I (insulin-dependent) diabetic patients. (2009) (25)
- Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. (1997) (24)
- Effects of everyday life events on glucose, insulin, and glucagon dynamics in continuous subcutaneous insulin infusion-treated type 1 diabetes: collection of clinical data for glucose modeling. (2012) (24)
- The transient effect of strict glycaemic control on B cell function in newly diagnosed Type 1 (insulin-dependent) diabetic patients (2004) (24)
- Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study (2017) (24)
- Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells. (2004) (24)
- Serum calcium fractions in diabetes mellitus. (1982) (23)
- IS DIABETIC OSTEOPOROSIS DUE TO MICROANGIOPATHY? (1981) (23)
- Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production (2017) (23)
- Hypoglycemia and Hemostatic Parameters in Juvenile-onset Diabetes (1980) (23)
- Updates in weight loss surgery and gastrointestinal peptides (2015) (23)
- Reproducibility of the Glucagon Test (1987) (23)
- Subcutaneous blood flow during insulin-induced hypoglycaemia: studies in juvenile diabetics with and without autonomic neuropathy and in normal subjects. (1982) (23)
- Lowered serum ionized calcium in insulin treated diabetic subjects. (1983) (23)
- Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial (2022) (23)
- Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives. (1999) (22)
- Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes (2010) (22)
- Plasma testosterone and androstenedione in insulin dependent patients at time of diagnosis and during the first year of insulin treatment. (1982) (21)
- No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery (2016) (21)
- Decreased serum concentration of ionized calcium in insulin‐dependent human diabetes mellitus (1983) (21)
- Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB (2017) (21)
- Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial. (2020) (21)
- β‐Cell dysfunction and low insulin clearance in insulin‐resistant human immunodeficiency virus (HIV)‐infected patients with lipodystrophy (2005) (20)
- Emerging drugs for the treatment of obesity (2017) (20)
- Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity (2017) (20)
- Extracellular Fluid Volume Expansion Uncovers a Natriuretic Action of GLP-1: A Functional GLP-1-Renal Axis in Man. (2019) (20)
- Increased glucose‐stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux‐en‐Y gastric bypass (2017) (20)
- Retinal function in relation to improved glycaemic control in type 1 diabetes (2011) (19)
- Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies (2021) (19)
- Insulin analogues: have they changed insulin treatment and improved glycaemic control? (2002) (19)
- Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. (2005) (19)
- Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report. (2013) (19)
- Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients. (1994) (18)
- Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes (2017) (18)
- Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1 (2011) (18)
- LY2605541—A Preferential Hepato-Specific Insulin Analogue (2014) (18)
- The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial (2018) (18)
- Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy1 (2004) (18)
- Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis (2020) (17)
- Efficacy and safety of dipeptidyl peptidase‐4 inhibitors as an add‐on to insulin treatment in patients with Type 2 diabetes: a review (2014) (17)
- Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial (2019) (17)
- Effects of surgical stress and insulin on cardiovascular function and norepinephrine kinetics. (1984) (17)
- Classification of Diabetes in Older Adults (1990) (16)
- Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) agonists: no. (2012) (16)
- Responses of gut and pancreatic hormones, bile acids and fibroblast growth factor-21 differ to glucose, protein and fat ingestion after gastric bypass surgery. (2020) (16)
- The Impact of Nocturnal Hypoglycemia on Sleep in Subjects With Type 2 Diabetes (2015) (16)
- Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus. (1985) (16)
- Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial (2016) (16)
- Clinical use of the co‐formulation of insulin degludec and insulin aspart (2016) (16)
- Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation. (1994) (15)
- Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs (2018) (15)
- Hormonal, metabolic and cardiovascular responses to hypoglycaemia in Type 1 (insulin-dependent) diabetes with and without residual B cell function (1982) (15)
- Liraglutide effects on beta‐cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes (2017) (15)
- T lymphocyte subsets in patients with newly diagnosed Type 1 (insulin-dependent) diabetes: A prospective study (1983) (15)
- Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol (2014) (15)
- Suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus: a prospective study. (1982) (15)
- Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine (2020) (15)
- Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance (2020) (15)
- Studies of association between LPIN1 variants and common metabolic phenotypes among 17,538 Danes. (2010) (15)
- Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients. (1998) (15)
- Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study (2016) (15)
- Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes (2015) (15)
- S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery (2017) (14)
- Liraglutide for treating type 1 diabetes (2016) (14)
- Effects of Roux-en-Y Gastric Bypass on Fasting and Postprandial Levels of the Inflammatory Markers YKL-40 and MCP-1 in Patients with Type 2 Diabetes and Glucose Tolerant Subjects (2013) (14)
- Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients. (2004) (14)
- Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic control. (2009) (14)
- The importance of plasma free insulin and counterregulatory hormones for the recovery of blood glucose following hypoglycaemia in type 1 diabetics. (1985) (14)
- Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery. (2019) (14)
- Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes (2017) (13)
- Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass. (2017) (13)
- Effect of bariatric surgery on plasma GDF15 in humans. (2019) (13)
- Control of Blood Glucose for People with Type 1 Diabetes: an in Vivo Study (2012) (13)
- Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes (2009) (13)
- GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report (2020) (13)
- Skeletal muscle structural lipids improve during weight-maintenance after a very low calorie dietary intervention (2009) (13)
- A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite. (2017) (13)
- Genetic Determinants of Weight Loss After Bariatric Surgery (2019) (13)
- Non-insulin pharmacological therapies for treating type 1 diabetes (2018) (13)
- Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus. (1982) (12)
- Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study (2015) (12)
- Genetic variation in the natriuretic peptide system, circulating natriuretic peptide levels, and blood pressure: an ambulatory blood pressure study. (2012) (12)
- Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study. (2000) (12)
- Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study (2018) (12)
- A longitudinal study of virus antibodies in patients with newly diagnosed type 1 (insulin-dependent) diabetes mellitus. (1984) (12)
- Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus. (1986) (12)
- Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study. (2010) (12)
- Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial (2019) (12)
- Nutrient re‐routing and altered gut‐islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux‐en‐Y gastric bypass (2017) (12)
- Whole Body Clearance of Norepinephrine (1983) (11)
- Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease (2019) (11)
- PLASMA SOMATOSTATIN INCREASES DURING HYPOGLYCAEMIA IN INSULIN‐DEPENDENT PATIENTS WITH AND WITHOUT B‐CELL FUNCTION (1983) (11)
- Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects (2018) (11)
- [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences]. (2005) (11)
- Tuning of Controller for Type 1 Diabetes Treatment with Stochastic Differential Equations (2012) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Augmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion. (2019) (11)
- Soluble urokinase plasminogen activator receptor, C‐reactive protein and triglyceride are associated with heart rate variability in non‐diabetic Danes (2013) (11)
- Very early changes in circulating T3 and rT3 during development of metabolic derangement in diabetic patients. (2009) (11)
- Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy (2020) (10)
- Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials (2019) (10)
- Beta-cell dysfunction following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation. (1994) (10)
- THE SIGNIFICANCE OF THE PORTAL INSULIN SECRETION IN INSULIN DEPENDENT PATIENTS WITH RESIDUAL β‐CELL FUNCTION: A SAFEGUARD AGAINST HORMONAL AND METABOLIC DERANGEMENT (1982) (10)
- Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes (2009) (10)
- Effects of carbohydrate restriction on postprandial glucose metabolism, beta-cell function, gut hormone secretion, and satiety in patients with type 2 diabetes. (2020) (10)
- Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha‐adrenergic receptors in HIV‐lipodystrophy: implications for fat distribution (2007) (10)
- Factors of importance for residual beta-cell function in type I diabetes mellitus. A review. (2009) (10)
- In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance. (2005) (9)
- Islet-cell antibodies and beta-cell function in insulin-dependent diabetics (2005) (9)
- Preoperative High-Dose Methylprednisolone and Glycemic Control Early After Total Hip and Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial (2018) (9)
- Major rapid weight loss induces changes in cardiac repolarization. (2016) (9)
- Under-reporting of adverse effects of tesofensine (2013) (9)
- Sex and muscle structural lipids in obese subjects – an impact on insulin action? (2008) (9)
- Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss (2009) (9)
- No interactions between polymorphisms in the β3-adrenergic receptor gene and the PPAR-γ gene on the risk of the insulin resistance syndrome in the Danish MONICA cohort (2003) (9)
- The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies. (2021) (9)
- Effect of a new starch-free bread on metabolic control in NIDDM patients. (1999) (9)
- Changes in T-lymphocyte subsets after elective surgery. (1986) (9)
- Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes (2017) (9)
- Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophy. (2006) (9)
- Effects of Bariatric Surgery on Weight Loss and Quality of Life (2014) (8)
- Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet (2019) (8)
- The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study (2021) (8)
- GIP may enhance fatty acid re-esterification in subcutaneous , abdominal adipose tissue in lean humans . Running title : GIP and lipid metabolism (2010) (8)
- Mechanisms Underlying Absent Training-Induced Improvement in Insulin Action in Lean, Hyperandrogenic Women With Polycystic Ovary Syndrome (2020) (8)
- Bariatric surgery—which procedure is the optimal choice? (2019) (8)
- Rapid changes in plasma androgens during insulin withdrawal in male Type 1 (insulin-dependent) diabetics (1986) (8)
- Sham feeding increases glucose tolerance by a mechanism independent of insulin secretion in normal subjects. (1995) (8)
- Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2 (2016) (8)
- Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics. (1987) (8)
- Effects of androgens on oxygen affinity in vivo and 2,3-diphosphoglycerate content of red cells in peripheral arterial insufficiency. (1976) (8)
- Sham-feeding decreases cardiac output in normal subjects. (1992) (8)
- Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status (2018) (8)
- The renal extraction and the natriuretic action of GLP-1 in humans depend on interaction with the GLP-1 receptor. (2020) (7)
- Impact of prolonged fasting on insulin secretion, insulin action and hepatic versus whole-body insulin secretion disposition indices in healthy young males. (2020) (7)
- Treatment with GLP-1 Receptor Agonists (2018) (7)
- No differential effects of porcine and human insulin on muscle sympathetic nerve activity during euglycaemia or hypoglycaemia. (1996) (7)
- Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics. (2009) (7)
- The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery. (2020) (7)
- Pancreatic β-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes (2010) (7)
- [The effect of tesofensine on body weight and body composition in obese subjects--secondary publication]. (2009) (6)
- Effect of pancreas transplantation and immunosuppression on proinsulin secretion (1998) (6)
- Desaturation of excess intramyocellular triacylglycerol in obesity: implications for glycemic control (2010) (6)
- Glycaemic control and weight loss with semaglutide in type 2 diabetes. (2017) (6)
- Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes (2019) (6)
- Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials (2021) (6)
- GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment. (2022) (6)
- Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials. (2017) (6)
- The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial (2018) (6)
- Relationship between Optimum Mini‐doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes – A Simulation Study (2018) (6)
- Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery—An observational cohort study of changes in urinary markers (2020) (6)
- On measurements of glucagon secretion in healthy, obese, and Roux-en-Y gastric bypass operated individuals using sandwich ELISA (2021) (6)
- Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery (2018) (6)
- The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study. (2020) (6)
- Effects of a highly controlled carbohydrate-reduced high-protein diet on markers of oxidatively generated nucleic acid modifications and inflammation in weight stable participants with type 2 diabetes; a randomized controlled trial (2020) (6)
- Liraglutide for the prevention of major adverse cardiovascular events in diabetic patients (2019) (6)
- Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT). (1993) (5)
- The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults (2019) (5)
- RESPONSE OF PANCREATIC POLYPEPTIDE TO HYPOGLYCAEMIA IN INSULIN‐DEPENDENT DIABETICS WITH AND WITHOUT RESIDUAL β‐CELL FUNCTION (1983) (5)
- Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes (2019) (5)
- Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls. (2019) (5)
- Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial (2020) (5)
- Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus (2020) (5)
- Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass (2019) (5)
- Body weight and metabolic risk factors in patients with type 2 diabetes on a self-selected high-protein low-carbohydrate diet (2021) (5)
- Colonic lactulose fermentation has no impact on glucagon-like peptide-1 and peptide-YY secretion in healthy young men. (2021) (5)
- [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes]. (2006) (5)
- Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients (2010) (5)
- Sustained low‐dose growth hormone therapy optimizes bioactive insulin‐like growth factor‐I level and may enhance CD4 T‐cell number in HIV infection (2010) (5)
- Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment (2022) (5)
- Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: a preliminary study. (2021) (4)
- Gastric bypass and duodenal and gastric feeding: a comment to Hansen et al. (2011) (4)
- Secretin release after Roux-en-Y Gastric Bypass reveals a population of glucose-sensitive S-cells in distal small intestine (2019) (4)
- Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus. (1984) (4)
- Simulating clinical studies of the glucoregulatory system: in vivo meets in silico (2017) (4)
- [The importance of physical activity and fitness in avoiding the complications of obesity]. (2006) (4)
- Insulin and New Insulin Analogues with Focus on Type 2 Diabetes (2007) (4)
- Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART. (2007) (4)
- Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes (2019) (4)
- Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function (1981) (4)
- β‐cell dysfunction and low insulin clearance in insulin‐resistant human immunodeficiency virus (HIV)‐infected patients with lipodystrophy (2006) (4)
- Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial (2021) (4)
- Defects in quantitative and qualitative β-cell function following successful segmental pancreas transplantation (1993) (4)
- A rapid method for determination of human C-peptide in plasma. (1991) (4)
- In vivo and in vitro degradation of peptide YY 3 – 36 to inactive peptide YY 3 – 34 in humans (2016) (4)
- Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration (2022) (4)
- [Smoking and diabetes mellitus]. (1989) (4)
- Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study (2019) (4)
- Type 2-diabetes. Medicinsk teknologivurdering af screening, diagnostik og behandling (2003) (4)
- Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP‐1 but not GIP, CCK, and gastrin in plasma (2020) (3)
- Effect of Insulin‐induced Hypoglycaemia on Absorption of Unmodified Insulin after Subcutaneous or Intramuscular Injection (1991) (3)
- Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report (2014) (3)
- After Roux-en-Y Gastric Bypass, Enterohepatic Bile Circulation Is Altered and Bile Acid Retention Increased while Bile Acid Homeostasis Remains Normal after Sleeve Gastrectomy (2018) (3)
- What is Diabetes Remission? (2021) (3)
- Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4. (2021) (3)
- Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls. (2005) (3)
- Suppressor cell activity and beta-cell function in insulin-dependent diabetics. (2009) (3)
- Bariatric surgery 2 Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery (2014) (3)
- Diabetes Mellitus: Type 2-diabetes (2012) (3)
- The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics. (1985) (3)
- Neurovascular Coupling in Type 2 Diabetes With Cognitive Decline. A Narrative Review of Neuroimaging Findings and Their Pathophysiological Implications (2022) (3)
- Effect of starch-free bread on metabolic control in type 2 diabetes (1998) (3)
- 35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
- Metabolic state does not influence lymphocyte subsets in type 1 diabetic patients. (1988) (3)
- Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes (2022) (3)
- Response to Comment on: Knop et al. (2007) Reduced Incretin Effect in Type 2 Diabetes: Cause or Consequence of the Diabetic State? Diabetes 56:1951–1959 (2008) (3)
- Studies of association of the CASQ1 rs2275703 polymorphism in relation to type 2 diabetes and related quantitative metabolic traits among 7,088 Danish whites. (2007) (3)
- [The endocrine and metabolic link between COVID-19, diabetes and obesity]. (2020) (3)
- Cardiovascular effects of incretins - focus on GLP-1 receptor agonists. (2022) (3)
- Genetic markers of abdominal obesity and weight loss after gastric bypass surgery (2021) (2)
- Early Weight Loss Responders to Liraglutide 3.0 mg had Greater Weight Loss, Regression to Normoglycemia and Reduced T2D Development at 3 Years vs. Early Non-Responders: SCALE Obesity and Prediabetes (2016) (2)
- Metformin and sulphonylurea (second‐ or third‐generation) combination therapy for adults with type 2 diabetes mellitus (2016) (2)
- [Obesity, the metabolic syndrome and cardiovascular disease]. (2004) (2)
- Evaluation of Two Methods of Rapid Blood‐Glucose Monitoring by Unskilled Personnel during Surgery (1984) (2)
- Treatment of hyperglycaemia in the elderly with diabetes mellitus (1990) (2)
- [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications]. (2003) (2)
- [Thiazolidinediones--a new class of oral antidiabetics]. (2001) (2)
- Type 2 diabetes: which drug as add-on to metformin? (2012) (2)
- Lack of negative feed-back regulation of insulin on the responses of gastric inhibitory polypeptide, insulin, glucagon and pancreatic polypeptide to a meal in insulin treated diabetics. (1984) (2)
- The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and β-cell function after Roux-en-Y gastric bypass and sleeve gastrectomy surgery. (2022) (2)
- Effects of a Self-Prepared Carbohydrate-Reduced High-Protein Diet on Cardiovascular Disease Risk Markers in Patients with Type 2 Diabetes (2021) (2)
- Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity (2021) (2)
- Reduced concentrations of intact and total GIP and GLP-1 in type 2 diabetic patients (2000) (2)
- Guidelines: Surgical or medical therapy for patients with obesity and T2DM? (2016) (2)
- 686-P: Exercise Alone and in Combination with Liraglutide Exert Clinically Relevant Improvements in Cardiorespiratory Fitness during 1-Year Weight Loss Maintenance: The S-LITE Randomized Trial (2020) (2)
- Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes (2019) (2)
- 22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts (2015) (2)
- Metabolic Health in Severely Obese Subjects: A Descriptive Study. (2019) (2)
- 59-OR: Liraglutide Preserved Insulin Secretion in Adults with Newly Diagnosed Type 1 Diabetes: The NewLira Trial (2019) (2)
- Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomised controlled trial. (2022) (2)
- No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes (2020) (2)
- Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass (2022) (2)
- Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes (2020) (2)
- Non‐Insulin Parenteral Therapies (2010) (2)
- Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c) (2010) (2)
- Consistent HbA1c and Body Weight Reduction with Semaglutide Independent of Diabetes Duration—SUSTAIN 1-5 and 7 Patient-Level Meta-analysis (2018) (1)
- [The glucagon-like peptide-1 receptor-agonist semaglutide]. (2019) (1)
- The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial (2018) (1)
- Heterogeneity of IR-GIP in Normal Subjects and Insulin-Dependent Diabetics (1987) (1)
- [Catecholamines and blood glucose]. (1984) (1)
- The Effect of Bariatric Surgery on Healthcare Costs and Labor Market Attachment (2022) (1)
- [The place of Glitazones in the treatment of diabetes: after the PROactive study]. (2006) (1)
- Follistatin secretion is enhanced by protein, but not glucose or fat ingestion in obese persons independently of previous gastric bypass surgery. (2021) (1)
- Increased metabolic sensitivity towards adrenaline in diabetic autonomic neuropathy (1985) (1)
- Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients. (1998) (1)
- [A proposal on the structuring of thyroid surgery and patient examination in Denmark]. (1991) (1)
- Author response for "Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2" (2021) (1)
- 19. Efficacy and Safety of Liraglutide Added to Insulin in Type 1 Diabetes: The LIRA-1 Trial (277-OR) (2015) (1)
- [Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus]. (1996) (1)
- [New discoveries about the cause of diabetes. Type 2 diabetes mellitus changed to "obesity-dependent diabetes mellitus"]. (2001) (1)
- Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial (2022) (1)
- PASSIVE TRANSFER IN DIABETES MELLITUS (1979) (1)
- Neurotensin secretion after Roux‐en‐Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty (2021) (1)
- Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus (2020) (1)
- Tesofensine and weight loss – Authors' reply (2009) (1)
- Passive transfer of diabetes mellitus. Abstr. (1978) (1)
- Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels (2016) (1)
- The effects of tesofensine on body composition in obese subjects (2008) (1)
- Smoking and insulin absorption. (1984) (1)
- Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy (2022) (1)
- Short-term changes in levels of circulating t3 and reverse T3 in Type 1 (insulin-dependent) diabetic patients (1983) (1)
- Erratum to semaglutide seems to be more effective the other GLP-1Ras. (2018) (1)
- Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity (2022) (1)
- The prevalence of comorbidities in Danish patients with obesity – A Danish register‐based study based on data from 2002 to 2018 (2022) (1)
- Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial (2023) (1)
- Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetes. (2020) (1)
- European Obesity Summit (EOS) – Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1 – 4, 2016: Abstracts (2016) (1)
- [Insulin absorption in smoking diabetics]. (1982) (1)
- Is Glycogen Synthase Kinase-3β an Ultraconserved Kernel Enzyme? (2009) (1)
- Assessment of Islet Alpha- and Beta-Cell Function (2019) (1)
- Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components. (2016) (1)
- Plasma GDF15 levels are similar between subjects after bariatric surgery and matched controls and are unaffected by meals. (2021) (1)
- Different percentages of CD8+ lymphocytes in long-term type 1 diabetics with and without residual beta cell function. (1989) (1)
- Obesity , Diabetes and Energy Homeostasis Variable reliability of surrogate measures of insulin sensitivity after Roux-enY gastric bypass X (2017) (1)
- [Successful treatment of KCNJ11 neonatal diabetes without insulin]. (2018) (1)
- Impaired conversion ofprednisone toprednisolone inpatients withliver cirrhosis (1980) (1)
- Semaglutide consistently reduces cardiovascular risk in patients with type 2 diabetes regardless of baseline cardiovascular risk level: post hoc analyses of the SUSTAIN trial programme (2018) (1)
- [Hypoglycemia in diabetes mellitus. Symptoms, epidemiology, physiopathology, causes and treatment]. (1992) (1)
- Protein and Glucose Absorption and Gastrointestinal Hormone Secretion Differ between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy (2018) (1)
- Human amylin, pramlintide and GLP-1: Influence on gastric emptying, appetite and food intake in humans (2008) (1)
- More predictable fasting blood glucose with the new soluble basal insulin analogue, insulin detemir: A comparison with NPH in type I diabetic patients (2000) (1)
- A randomized-controlled trial of tesomet resulted in significant weight loss in hypopituitary patients with hypothalamic obesity (2020) (1)
- Metabolic responses to hypoglycemia in juvenile diabetics. (2009) (1)
- Glucagon-like-peptide-1 (GLP-1) is important for the improved β-cell function in type 2 diabetic subjects after Roux-en-Y gastric bypass (RYGB) (2012) (1)
- Insulin Secretion in Relatives of NIDDM patients (1996) (1)
- 38-LB: Reduced Carbohydrate and Increased Protein and Fat during Weight Loss Improve the Atherogenic Lipid Profile in Type 2 Diabetes (2021) (1)
- Liraglutide as Add-on to Oral Antidiabetic Agents or Insulin in Routine Practice of Patients with Type 2 Diabetes (2014) (1)
- Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota (2016) (1)
- Dulaglutide for erectile dysfunction in type 2 diabetes. (2021) (1)
- LY2605541—A Preferential Hepato-Specific Insulin (2014) (1)
- [Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review]. (2007) (1)
- Ætiologi og patogenese, type 2 diabetes (2011) (0)
- Metabolic control and bone turnover after Roux-en-Y gastric bypass in response to weight loss and weight stabilisation (2017) (0)
- Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial (2022) (0)
- [Diabetes mellitus and surgery]. (1987) (0)
- 216-LB: Development and Evaluation of a Glucagon Sensitivity Test in Humans (2021) (0)
- Serum Calcium Fractionsin DiabetesMellitus (1982) (0)
- ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hypothalamic Obesity (2022) (0)
- Review for "Amino Acids Are Sensitive Glucagon Receptor Specific Biomarkers for Glucagon‐Like Peptide 1 Receptor/Glucagon Receptor Dual Agonists" (2020) (0)
- Quality of life, patient satisfaction, and cardiovascular outcomes of the randomised 2 x 3 factorial Copenhagen insulin and Metformin therapy (CIMT) trial – A detailed statistical analysis plan (2023) (0)
- Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report (2014) (0)
- [Obesity and type 2 diabetes. Therapeutic failures]. (2000) (0)
- Effects of Carbohydrate Restriction on Body Weight and Glycemic Control in Individuals with Type 2 Diabetes: A Randomized Controlled Trial of Efficacy in Real-Life Settings (2022) (0)
- Effects of Simple Carbohydrates on GLP-1 Responses in Gastric Bypass Patients and Matched Controls (2018) (0)
- Does glucose lowering restore GIP´s effect on insulin secretion? (2023) (0)
- Review for "The Dual GIP and GLP ‐1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Biomarkers in Patients with Type 2 Diabetes: a Post‐Hoc Analysis" (2021) (0)
- EASD News Section (2005) (0)
- The effect of tesofensine on weight loss: results from a one-armed, open-labelled extension study (2009) (0)
- The GLP-1 analogue liraglutide improves first-phase insulin secretion and maximal beta-cell secretory capacity over 14 weeks of therapy in subjects with Type 2 diabetese (2007) (0)
- 321-OR: Empagliflozin Improves Beta-Cell Function Independently of Glucose Toxicity in Patients with Type 2 Diabetes (2022) (0)
- Author response for "Efficacy and Safety of Liraglutide in Type 1 Diabetes by Baseline Characteristics in the ADJUNCT ONE and ADJUNCT TWO Randomized Clinical Trials" (2021) (0)
- 36-LB: The Effect of Dietary Carbohydrate Restriction on Health-Related Quality of Life and Cognition: A Randomized Trial (2021) (0)
- Cover Image, Volume 22, Issue 10 (2020) (0)
- [Biotransformation of prednisone to prednisolone in patients with liver cirrhosis]. (1979) (0)
- [Treatment of diabetes during hospitalization--still a challenge]. (2011) (0)
- 59 - Greater Reductions in HbA1c and Body Weight With Once-Weekly Semaglutide Vs Comparators Across Baseline BMI Subgroups: Posthoc Analysis of SUSTAIN 1–5 and 7–10 (2020) (0)
- Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass (2021) (0)
- [New pharmacological treatment methods of type 2 diabetes]. (2012) (0)
- [New biological drugs for the treatment of chronic inflammatory diseases]. (2008) (0)
- 1425-P: Effect of Ghrelin on Glucose Tolerance after Sleeve Gastrectomy (2022) (0)
- Skeletal muscle insulin signaling defects downstream of PI3K at the level of Akt are associated with impaired non-oxidative glucose disposal in HIV-lipodystrophy (2005) (0)
- At tro, at 50-60 årig ekan tabe sig, er naivt (2010) (0)
- Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes. (2021) (0)
- 1343-P: The Acute Effects of Glucagon on Glucose Dynamics Are Not Impaired in Individuals with Nonalcoholic Fatty Liver Disease (2022) (0)
- Validation of a Simulation Model Describing the Glucose-Insulin-Glucagon Pharmacodynamics in Patients with Type 1 Diabetes (2017) (0)
- Effect of Glucagon-Like Peptide-1 on (cid:1) - and (cid:2) -Cell Function in C-Peptide-Negative Type 1 Diabetic Patients (2010) (0)
- Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function (2023) (0)
- Diabetes Mellitus: Type 1-diabetes og hypoglykæmi (2012) (0)
- 933-P: Greater Reductions in HbA1c and Body Weight with Once-Weekly Semaglutide vs. Comparators across Baseline BMI Subgroups: A Post Hoc Analysis of SUSTAIN 1-5 and 7-10 (2020) (0)
- Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study (2019) (0)
- 1966-P: Manipulating Postprandial Bile Acid Concentrations: Effect on GLP-1 Secretion after Roux-en-Y Gastric Bypass (2019) (0)
- Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels (2016) (0)
- OP5 THE IMPACT OF NOCTURNAL HYPOGLYCAEMIA ON SLEEP IN SUBJECTS WITH TYPE 2 DIABETES (2014) (0)
- Postoperative morbidity in diabetics after fast-track primary total hip and knee arthroplasty: ESAAP2-2 (2013) (0)
- Plasma from insulin-dependent diabetics inhibits theophylline sensitive T-lymphocytes demonstrated in E-rosette assay. (1983) (0)
- and unchanged glucose effectiveness in patients with type 2 diabetes (2015) (0)
- 1971-P: SGLT1-Mediated Glucose Absorption Is Important for Incretin Hormone Secretion after Gastric Bypass Surgery (2019) (0)
- The impact of nocturnal hypoglycaemia on sleep in subjects with type 2 diabetes (2015) (0)
- Body composition at onset of type 1 diabetes and during the first year of insulin therapy (2000) (0)
- Insufficient sleep predicts poor weight loss maintenance after one year. (2022) (0)
- Liraglutide (Victoza) - the first once-daily human GLP-1 receptor analogue (2009) (0)
- Effect of major surgery on absorption rate of NPH insulin injected s.c. (1990) (0)
- Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial (2022) (0)
- [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes]. (2002) (0)
- Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes (2021) (0)
- [Is the incidence of alcoholic liver cirrhosis in young patients increasing?]. (1977) (0)
- Reply - Letter to the editor – “Weight-loss induced by carbohydrate restriction does not negatively affect health-related quality of life and cognition in people with type 2 diabetes: A randomized controlled trial” Clinical Nutrition 2022 (2022) (0)
- Effect of Insulin and Elevated Free Fatty Acids on Plasma TNF-Alfa and IL-6 Concentrations (2002) (0)
- Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight (2022) (0)
- Development of a glucagon sensitivity test in humans: Pilot data and the GLUSENTIC study protocol (2022) (0)
- Omega-3 long chain fatty acid content in the skeletal muscle membrane increases during diet intervention in obese patients with or without type 2 diabetes mellitus (2000) (0)
- Treatment of the Metabolic Syndrome by Bariatric Surgery (2013) (0)
- Fractionated free fatty acids and their relation to diabetes status after Roux‐en‐Y gastric bypass: A cohort study (2021) (0)
- 1917-P: Primary Weight Loss Failure after Gastric Bypass Is Characterized by Impaired Gut-Hormone-Mediated Suppression of Food Intake (2019) (0)
- [Diabetic nephropathy. A modifiable risk factor]. (2000) (0)
- 139-OR: Superior Effect of 1-Year Treatment with GLP-1 Receptor Agonist and Exercise on Weight Loss Maintenance and Body Composition after a Very Low-Calorie Diet: The S-LITE Randomized Trial (2020) (0)
- Author response for "The antiresorptive effect of GIP , but not GLP ‐2, is preserved in patients with hypoparathyroidism– a randomized crossover study" (2021) (0)
- [Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes]. (2016) (0)
- Increased meal-induced neurotensin response predicts successful maintenance of weight loss - Data from a randomized controlled trial. (2023) (0)
- Postprandial secretion of follistatin after gastric bypass surgery and sleeve gastrectomy (2023) (0)
- [Transplantation of pancreas and islet cells in insulin dependent diabetes mellitus--status after 25 years]. (1992) (0)
- [Medical complications associated with bariatric surgery]. (2014) (0)
- [Type 2-diabetes--a coherent health care system needed]. (2012) (0)
- [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes]. (2002) (0)
- [Severe obesity in children and adolescents – a condition without effective treatment?]. (2015) (0)
- [Surgical treatment of diabetes mellitus type 2]. (2009) (0)
- [HIV-associated lipodystrophy syndrome. Diagnosis, prevalence, pathogenesis and metabolic complications]. (2003) (0)
- [Thiazolidinediones- - new class of oral antidiabetics]: Thiazolidinedioner- en ny klasse af orale antidiabetika (2001) (0)
- Oral Communications (2006) (0)
- [The clinical picture in insulin overdosage and counterregulation]. (1979) (0)
- 716-P: Reduced Carbohydrate and Increased Protein and Fat in the Diet Augment the Positive Effect of Weight Loss on Glucose Control in Type 2 Diabetes Patients (2020) (0)
- Improvement in insulin sensitivity in Type 1 diabetic patients following low fat diet (2000) (0)
- Review for "Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes" (2020) (0)
- [Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review]. (2011) (0)
- 77-OR: The Gut Peptide Neurotensin Does Not Reduce Appetite and Food Intake in Healthy Young Men (2020) (0)
- The Glucagon/C-peptide Test in the Discrimination of Insulin-dependent from Non-insulin-dependent Diabetes (1986) (0)
- 734-P: The Effect of Adjunctive Therapy with Liraglutide on Insulin Sensitivity in Overweight Persons with Type 1 Diabetes (2022) (0)
- No reactive hypoglycemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and I.V. glucose (2000) (0)
- Early effects of Roux-en-Y gastric bypass on dietary fatty acid absorption and metabolism in people with obesity and normal glucose tolerance (2022) (0)
- Challenges in the treatment of young people with type 2 diabetes. (2023) (0)
- Greater weight loss and regression to normoglycaemia, and reduced risk of T2D, at 3 years in early weight loss responders to liraglutide 3.0 mg vs early non-responders (2016) (0)
- Parasympathetic tonus in type 2 diabetes and pre-diabetes and its clinical implications (2022) (0)
- Subcutaneous GLP-1 reduces plasma glucose but may induce tachyphylaxis in type 2 diabetic patients (2000) (0)
- 1974-P: Diet-Induced Weight Loss Improves Sleep Quality and These Improvements Are Sustained with One Year of Weight Maintenance with Exercise: The S-LITE Randomized Trial (2020) (0)
- The Risk of Developing Type 2 Diabetes after Different Types of Colorectal Cancer Surgery: Nationwide Cohort Study in Denmark (2022) (0)
- Outcomes in diabetics after fast-track total hip and knee arthroplasty (2012) (0)
- Lack of influence of residual beta-cell function on the glucagon and pancreatic polypeptide secretion in type I (insulin-dependent) diabetic patients. (1987) (0)
- Reply - Letter to the editor - On carbohydrate restriction and health-related quality of life and cognition in type 2 diabetes. (2022) (0)
- Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial. (2021) (0)
- 876-P: Empagliflozin-Induced Metabolic Changes and Cardiac Function in Patients with Type 2 Diabetes: A Randomized Crossover MRI Study with Insulin as Comparator (2022) (0)
- [Insulin allergy]. (1986) (0)
- Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist (2019) (0)
- Changes in beta cell function and insulinotropic effect of the incretin hormones 1week after Roux-en-Y gastric bypass surgery in subjects with normal glucose tolerance (2012) (0)
- 355-OR: Effects of a Six-Week Intervention with Glucagon-Like Peptide-1 Analogue on Pancreatic Volume, Edema, and DNA Synthesis in Obese Men (2020) (0)
- 2028-P: Adding Exercise to Liraglutide Treatment in Weight Loss Maintenance Abolishes the Increase in Heart Rate Seen with Liraglutide Alone: The S-LITE Randomized Trial (2020) (0)
- Significant weight loss resulted in reduced levothyroxine requirements during a tesomet trial of hypopituitary patients with acquired hypothalamic obesity (2022) (0)
- 1956-P: Increased Salt Intake Amplifies the Postprandial Glucagon-Like Peptide-1 Secretion (2019) (0)
- Author’s response to reviews Title: GASTRIC BYPASS SURGERY REVEALS INDEPENDENCY OF OBESITY AND DIABETES MELITUS TYPE 2 Authors: (2016) (0)
- 1909-P: The Natriuretic Action of Glucagon-Like Peptide-1 in Humans Is Abolished by the GLP-1 Receptor Antagonist Exendin 9-39 (2020) (0)
- [Treatment of hyperglycemia in patients with type 2 diabetes and cardiovascular disease]. (2016) (0)
- Comparative studies of insulin vs glucagon‐like peptide‐1 receptor agonists in patients initiating injectable therapy (2017) (0)
- No impact of low birth weight per se on in vivo insulin action in young men (2000) (0)
- The proposed terminology ‘A1c-derived average glucose’ is inherently imprecise and should not be adopted. Reply to Bloomgarden ZT, Inzucchi SE, Karnieli E, et al. [letter] (2009) (0)
- [Control and treatment of HIV-associated lipodystrophy syndrome and related metabolic complications]. (2003) (0)
- New Treatments: Liraglutide (2006) (0)
- Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter] (2022) (0)
- Author response for "No effects of a six‐week intervention with glucagon‐like peptide‐1 receptor analogue on pancreatic volume and edema in obese men without diabetes" (2020) (0)
- Glucose Metabolism After Menopause (2007) (0)
- [Weight loss treatment of obese type 2 diabetic patients]. (2006) (0)
- CD4 T-cell count improves during sustained IGF-I response following low dose growth hormone therapy in HIV-infected patients on stable antiretroviral regimens. A pilot study (2006) (0)
- Changes in dak adaptation and retinal electroretinographic function after 1 year of sustained glycemia reduction in patients with type 1 diabetes (2011) (0)
- [Preservation and regeneration of residual function of the beta cells in insulin-dependent diabetics]. (1981) (0)
- [Glycemic control and cardiovascular diseases in type 2 diabetes]. (2008) (0)
- Extracellular Volume Expansion Uncovers a Natriuretic Action of Glucagon-Like Peptide-1 (2018) (0)
- 675-P: Effects of Liraglutide in T1D by Baseline Anthropometrics in ADJUNCT One and Two (2021) (0)
- RUNNING TITLE: GLP1 and βcell function in type 2 diabetes after RYGB (2013) (0)
- [Conventional insulin treatment and treatment using multiple injections in diabetes mellitus]. (1989) (0)
- Liraglutide, the first once-daily human GLP-1 receptor analogue (2009) (0)
- Peripheral plasma C-peptide levels do not accuratly reflext prehepatic insulin secretion after intravenous glucose (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sten Madsbad?
Sten Madsbad is affiliated with the following schools:
